1. Home
  2. ALLR vs UONEK Comparison

ALLR vs UONEK Comparison

Compare ALLR & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

N/A

Current Price

$0.98

Market Cap

19.3M

Sector

Health Care

ML Signal

N/A

Logo Urban One Inc. Class D

UONEK

Urban One Inc. Class D

BUY

Current Price

$3.86

Market Cap

19.9M

ML Signal

BUY

Company Overview

Basic Information
Metric
ALLR
UONEK
Founded
2004
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
19.3M
19.9M
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
ALLR
UONEK
Price
$0.98
$3.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 107.6K
3.6K
Earning Date
11-13-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$320,000.00
★ $439,098,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.77
$0.45
52 Week High
$1.84
$9.38

Technical Indicators

Market Signals
Indicator
ALLR
UONEK
Relative Strength Index (RSI) 33.62 43.52
Support Level $0.90 $3.58
Resistance Level $1.00 $5.05
Average True Range (ATR) 0.09 0.23
MACD -0.00 0.02
Stochastic Oscillator 18.69 33.33

Price Performance

Historical Comparison
ALLR
UONEK

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: